A renowned healthcare growth equity firm, Foresite announced the addition of another venture member to their team. The coming of Dr. He Molly was highly exciting according to Foresite’s CEO. The excitement comes because Dr. Molly brings with her an excellent wealth of experience in a field that not many scientists have excelled. With more than 15 years in the pharmaceutical and genomic research and development, Dr. He provides an opportunity for Foresite to grow a different portfolio under her leadership.
Jim Tananbaum, the CEO and MD of Foresite is thrilled because of this move. He believes that Dr. He will be bringing her experience and expertise in genomic and drug development. She sets a remarkable record of leadership, and she is sure to be a valuable resource in the expansion of the company.
In an article on Wired, Dr. He is also happy to be joining the team of expert and acknowledges that the company, Foresite, has been a force behind some of the most influential researches. She is happy to be part of the team and believes that she will contribute towards expanding the company’s portfolio.
About Jim Tananbaum
Dr. Tananbaum is the founder of Foresite capital. He is the industry leader and has over 25 years of experience in investment and health care entrepreneurship. His focus is on the strategic, financial and operational opportunities that are responsible for building health care businesses. In his 25-year career period, he has been at the helm of either founding or helping start health franchises in all segments of the economy. Jim Tananbaum is well noted for being the founder of GeITex Pharmaceuticals early in his career. This company was responsible for bringing two new drugs to the market. It was sold at a 1.6billion dollar worth. He has also been a founder of several other organizations including prospect venture partners and Theravance Inc. where he has been a co-founder.